Black Diamond Therapeutics, Inc. · NASDAQ:BDTX

BlackRock, Inc.'s stake in Black Diamond Therapeutics, Inc. fell to 4.50% (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 29, 2025

BlackRock, Inc.'s stake in Black Diamond Therapeutics, Inc. fell to 4.50%, 2,523,521 shares, as a passive investor on Mar 31, 2025. Filed Apr 29, 2025 (Schedule 13G/A).

Stake
4.50%
Shares
2,523,521
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
BlackRock, Inc.4.50%2,523,521

Source

View original at SEC

Related